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The  VP2 gene  of infectious  pancreatic  necrosis  virus,  encoded  in  an expression  plasmid
and  encapsulated  in  alginate  microspheres,  was  used  for oral DNA vaccination  of  ﬁsh  to
better understand  the  carrier  state  and the  action  of  the  vaccine.  The  efﬁcacy  of  the  vaccine
was  evaluated  by measuring  the prevention  of virus  persistence  in the  vaccinated  ﬁsh  that
survived  after  waterborne  virus  challenge.  A real-time  RT-qPCR  analysis  revealed  lower
levels  of IPNV-VP4  transcripts  in rainbow  trout survivors  among  vaccinated  and  challenged
ﬁsh compared  with  the  control  virus  group  at  45  days  post-infection.  The  infective  virus
was  recovered  from  asymptomatic  virus  control  ﬁsh,  but not  from  the  vaccinated  survivor
ﬁsh, suggesting  an  active  role  of the  vaccine  in  the  control  of  IPNV  infection.  Moreover,  the
levels  of IPNV  and  immune-related  gene  expression  were  quantiﬁed  in  ﬁsh  showing  clinical
infection  as well  as in asymptomatic  rainbow  trout  survivors.  The  vaccine  mimicked  the
action  of  the  virus,  although  stronger  expression  of  immune-related  genes,  except  for IFN-
1 and  IL12,  was  detected  in survivors  from  the  virus  control  (carrier)  group than  in those
from  the  vaccinated  group.  The  transcriptional  levels  of  the  examined  genes  also  showed
signiﬁcant  differences  in the  virus  control  ﬁsh at 10 and  45  days  post-challenge.
©  2015  The  Authors.  Published  by  Elsevier  B.V.  This  is an  open  access  article  under  the  CC
Y-NC-NB
. Introduction
Infectious pancreatic necrosis virus (IPNV) is the aeti-
logical agent of infectious pancreatic necrosis disease,
hich causes high mortality in cultured salmonid ﬁsh.
lthough IPNV is not one of the disease agents listed by the
orld Organisation for Animal Health (OIE), it represents
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a problem for the freshwater aquaculture industry due to
its worldwide dispersal and the important economic losses
that it causes.
IPNV belongs to the Birnaviridae family and is the
archetypical species of the Aquabirnavirus genus, whose
members are naked, icosahedral viruses with a shell that is
60 nm in diameter and harbour a two-segmented, double-
stranded RNA genome (Dobos, 1995). Genome segment A
is approximately 3100 nucleotides (nt) in length and con-
tains two partially overlapping open reading frames (ORF).
One ORF is a short fragment encoding a 12–17-kDa protein
designated VP5. The other, longer, ORF encodes a 106-kDa
precursor protein that is co-translationally cleaved by the
viral VP4 protease, generating the structural VP2 and VP3
proteins. The smaller genomic segment B is 2784 nt long
ss article under the CC BY-NC-ND license (http://creativecommons.org/
logy an128 N.A. Ballesteros et al. / Veterinary Immuno
and encodes VP1, the virion-associated RNA-dependent
RNA polymerase.
IPNV infects young ﬁsh in fresh water and post-
smolts shortly after transfer to seawater (Evensen, 2008;
Ronneseth et al., 2013), resulting in an acute disease and
high mortality. Following infection, the ﬁsh are life-long
carriers of the virus, shedding it to their surroundings
through their faeces, urine and reproductive tract, thereby
transmitting the virus to their progeny and other suscep-
tible ﬁsh. Therefore, broodstock carriage is considered a
source of the virus for lethal infection of hatchery-reared
fry (Wolf, 1988). Indeed, this virus has been successfully
detected in macrophages from the head kidney (Johansen
and Sommer, 1995) and in leucocytes in the blood and
head kidney in survivors after infection (Rodriguez Saint-
Jean et al., 1991). Commercial seawater salmon farms may
also harbour IPNV carriers, and it appears that IPNV out-
breaks in seawater may  be more important economically
than freshwater outbreaks in fry (Melby et al., 1991).
IPNV persistence was ﬁrst described and studied in
infected cell lines in the 1980s (Hedrick and Fryer, 1981,
1982; Hedrick et al., 1978; Okamoto et al., 1983). Interest
in persistence has recently been renewed, given that more
accurate analysis and quantiﬁcation of target molecules is
now possible using techniques such as real-time PCR (qRT-
PCR), enabling connections with the immune response
to be assessed (Kileng et al., 2007; Marjara et al., 2010;
Rodríguez Saint-Jean et al., 2010). Indeed, this technique is
particularly useful for the study of viral carriers. The pres-
ence of the virus within the immune cells themselves may
signiﬁcantly affect the functions of the cells involved in
immunity. Therefore, the investigation of experimentally
induced IPNV persistence in trout may  shed light on viral
relapse and immune modulation during long-term infec-
tion, in addition to allowing testing of antiviral therapies
and new vaccines.
Oral DNA vaccines are now beginning to be tested in ﬁsh
as a new strategy for improving viral ﬁsh vaccines (Hølvold
et al., 2014). In this context, microencapsulation is a good
choice for plasmid delivery. We  have previously reported
the activity induced by a DNA vaccine that expresses the
VP2 gene of IPNV (de Las Heras et al., 2009). Protection
as high as a relative per cent survival (RPS) of 83% was
observed after oral vaccination of trout with the pcDNA-
VP2 plasmid encapsulated with alginates (de las Heras
et al., 2010), associated with the production of neutralising
antibodies that lasted for at least 60 days. We  subsequently
studied the differential expression of immune-related gene
transcripts on the 7th day following oral vaccination
with this VP2 gene using a newly designed oligo-
microarray of Oncorhynchus mykiss genes (Ballesteros et al.,
2012a).
In this study, a group of previously identiﬁed up-
regulated genes was selected for further study in the
context of acute and chronic IPNV infections and in vac-
cinated ﬁsh. Moreover, we aimed to quantify the levels of
IPNV in rainbow trout survivors among both virus con-
trol group and ﬁsh that were challenged with the virus
after oral vaccination. IPNV was detected via qRT-PCR of
the VP4 gene, a non-structural gene of IPNV, to determine
whether the virus was present in the VP2-vaccinated ﬁsh.d Immunopathology 165 (2015) 127–137
The immune responses induced in all the asymptomatic
ﬁsh were also evaluated to better understand the carrier
state and action of the vaccine. We  analysed the possible
resistance to the virus in the vaccinated ﬁsh by compar-
ing the relative number of IPNV carrier ﬁsh as well as
the expression of IFN genes and some interleukin (IL),
immunoglobulin (Ig) and major histocompatibility com-
plex (MHC-1) genes in the vaccinated and infected trout.
The infective virus was recovered from infected ﬁsh sur-
vivors that did not exhibit clinical symptoms, but not from
the vaccinated survivor ﬁsh.
2. Materials and methods
2.1. Cells and virus
The BF-2 cell line from bluegill fry (Lepomis macrochirus
Raﬁnesque 1819, ATCC-CCL 91) was  used in this study. The
BF-2 cells were cultured as previously described (Rodríguez
Saint-Jean et al., 2010). Brieﬂy, the cells were grown at
25 ◦C in Leibovitz’s medium (L-15, Gibco, Fisher Scientiﬁc,
Madrid, Spain) supplemented with 100 IU mL−1 of peni-
cillin G, 100 g mL−1 of streptomycin, 2 mM l-glutamine
and 10% foetal bovine serum (FBS: Gibco) or with 2% FBS in
the maintenance medium (MM).  The IPNV Sp strain (ATCC
VR 1318) was used in this study. The virus was propagated
in BF-2 cells at 19 ± 1 ◦C.
2.2. Fish
Rainbow trout (mean size and weight of 3.5–4 cm and
1.5 g, respectively) were purchased from a local spring
water farm with no history of viral disease. The ﬁsh were
kept under a 12/12 h light/dark regime at 15 ◦C in 350-
L closed re-circulating water tanks (Living Stream, Frigid
Units Inc., Ohio) at the Centro de Investigaciones Biológicas
(CSIC, Madrid, Spain). The ﬁsh were fed daily with a diet of
commercial pellets and were acclimatised to the aquarium
system at least 2 weeks prior to experimentation. To assess
their health, pools of ﬁve ﬁsh were examined for virus using
standard protocols (Anonymous, 2012). Likewise, BF-2 cells
were inoculated with dilutions of homogenates obtained
from the ﬁsh, then incubated at 15 ◦C and observed daily
for possible cytopathic effects (CPEs). None of the examined
ﬁsh lots showed positive results. The described exper-
iments complied with the Guidelines of the European
Union Council (86/609/EU) for the use of laboratory ani-
mals and were previously approved by the CSIC Ethics
Committee.
2.3. Oral vaccine against IPNV
The DNA vaccine (pcDNA-VP2) was prepared as pre-
viously described (de Las Heras et al., 2009), with the
IPNV-VP2 gene inserted into the pcDNA.3.1/V5/His-TOPO
vaccine vector (Invitrogen, USA). The pcDNA-VP2 and
pcDNA plasmids were coated with alginate; these micro-
spheres were prepared as described elsewhere (de las
Heras et al., 2010).
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.4. Experimental design
Vaccinated and mock-vaccinated ﬁsh challenged with
PNV at 15 days pv were observed for 45 days post-
hallenge, and the following assessments were then
erformed: (1) cumulative mortality and the relative per
ent survival; (2) viral persistence, by quantiﬁcation (RT-
PCR) of VP4 viral gene expression in organ samples; (3) the
evels of VP3 IPNV antigens in ﬁsh survivors, by ﬂow cytom-
try; (4) isolation of the virus in cell cultures; and (5) the
xpression levels of IFN and other immune-related genes.
he expression levels of these genes in ﬁsh with sub-clinical
nfections (45 days post-challenge) were compared with
hose in ﬁsh that were sampled at 10 days post-challenge
hen the infection was clinically evident. A sampling peri-
ds of 10 days was considered here because some genes
elated to both innate and speciﬁc immune responses have
een previously detected at approximately 7–15 days post-
hallenge (de las Heras et al., 2010; Ballesteros et al., 2014).
.5. Immunisation
The trout were distributed in separate 45-L tanks (25
sh each), supplied with non-chlorinated water using
xterior carbon ﬁlters (Eheim, Germany) and additional
eration. The experiment included three treatment groups:
sh that were orally vaccinated with 10 g of DNA/plasmid
er ﬁsh diluted in 10 L of saline buffer (pcDNA-VP2
roup); ﬁsh that received similar amounts of microspheres
ontaining the empty plasmid (pcDNA group); and mock-
accinated control ﬁsh. Vaccination was performed with
n automatic 20-L pipette tip as previously described
Ballesteros et al., 2012a; de las Heras et al., 2010). The
ater quality was maintained at optimum levels, and the
onditions in all the tanks were equivalent.
.6. Challenge with IPNV and sampling
At 15 days post-vaccination (pv), the ﬁsh (two tanks per
roup, 20 ﬁsh per tank) were challenged via immersion
ith IPNV at a dose of 5 × 105 TCID50 mL−1 for 2 h at 15 ◦C
n a total volume of 4 L of dechlorinated and aerated water
er tank. The ﬁsh were held in 45-L aquaria, and mortality
as recorded daily for 45 days post-infection (pi). The ﬁsh
urviving at 45 days post-challenge when mortality ceased
ere sampled. At the time of sampling, the ﬁsh were sac-
iﬁced with an overdose of MS-222, and the liver, spleen,
idney, pyloric caeca and gill tissues were removed asepti-
ally and preserved in RNAlater (Ambion Inc.). Samples of
isceral pools were also collected for virus isolation in cell
ultures.
Cumulative mortality was also assessed in parallel
xperiments. The mortality in the tanks was recorded
aily, and the experiment was evaluated at 45 days post-
hallenge. The RPS was then calculated using the formula
PS = [1 − % (mortality of ﬁsh given vaccine/% mortality of
sh given pcDNA)] × 100. The identity of IPNV in the dead
sh was conﬁrmed through seroneutralisation with poly-
lonal antiserum or through ampliﬁcation of the VP4 viral
ene. Immunopathology 165 (2015) 127–137 129
2.7. RNA extraction, cDNA synthesis and real-time PCR
(qPCR)
The organ tissue samples stored at −20 ◦C in RNA later
were homogenised in a TissueLyser Lt (Qiagen, Madrid,
Spain). RNA was extracted using TRIzol LS (Invitrogen)
and treated with DNase I according to the manufacturer’s
instructions. The concentration and purity of the RNA were
measured spectrophotometrically (NanoDrop Technolo-
gies, USA, -www.nanodrop.com-), and for cDNA synthesis,
total RNA (5 g) was  primed with 25 pmol/L  of oligo-
d(T) and reverse-transcribed using the Super ScriptTM II Kit
(Invitrogen, USA). The obtained cDNA was stored at −20 ◦C
for further experiments.
Real-time PCR ampliﬁcation was performed in an iCy-
cler iQ Real-Time PCR Detection System (Bio-Rad, Madrid,
Spain) using the Quantimix Easy Kit (Biotools Labs, Spain)
and SYBR green, as described elsewhere (Ballesteros et al.,
2012b,c). Each ampliﬁcation reaction (20 L) contained
10 L of 2× Quantimix Easy Master Mix, 2 L of cDNA,
1 L (10 mM)  of forward and reverse primers and 6 L of
nuclease-free water. Negative controls without the tem-
plate (cDNA) were included. Elongation factor 1 (EF-1)
was used as a housekeeping control gene, and all the PCR
ampliﬁcations were performed in duplicate. The cycling
conditions were 95 ◦C for 5 min, followed by 45 cycles of
95 ◦C for 15 s and 60 ◦C for 1 min. After a run, melting curve
analyses were performed for each amplicon to ensure the
speciﬁcity of the primers. The obtained data were analysed
using iQ5 optical system software, version 2.0 (Bio-Rad),
and the expression of the target genes was  corrected based
on the endogenous control expression (EF-1) and calcu-
lated as the relative values (2−CT) or fold change in relative
expression according to the 2−CT method (Livak and
Schmittgen, 2001).
2.8. Persistence of IPNV: detection of VP4 mRNA
expression
The VP4 gene was quantiﬁed via RT qPCR as previously
described (Ballesteros et al., 2014). The ﬁsh surviving at 45
days pi were sacriﬁced, and their kidney, gill, liver, pyloric
caeca and spleen tissues were removed aseptically. Then,
total RNA was  isolated using the TRIzol reagent (Invitro-
gen, USA), from which cDNAs were synthesised (primers
in Table 1).
2.9. Detection of IPNV antigens in ﬁsh survivors by ﬂow
cytometry
Flow cytometry assays were performed in BF-2 cells
inoculated with homogenates of organs from asymp-
tomatic surviving trout at 45 days pi. The ﬁsh were
examined through indirect immunoﬂuorescence, and the
percentages of cells expressing the IPNV-VP3 protein were
determined as previously described (Pérez et al., 1994;
Rodriguez et al., 2001). Brieﬂy, the organs from three ﬁsh
were individually homogenised in L-15 medium supple-
mented with 2% FBS, followed by centrifugation at 800 × g
for 15 min. BF-2 cells were inoculated with different dilu-
tions of the supernatants and incubated at 20 ◦C. After 3
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Table 1
List of primer pairs designed for gene expression analysis by qRT-PCR.
Genes Primer sequence 5′–3′: Forward
Reverse
Accession Number
IFN1 AAAACTGTTTGATGGGAATATGAAA
CGTTTCAGTCTCCTCTCAGGTT
NM 001124531
IFN  CTGAAAGTCCACTATAAGATCTCCA
CCCTGGACTGTGGTGTCAC
FM864345.1
IL8 GAATGTCAGCCAGCCTTGTC
TCCAGACAAATCTCCTGACCG
AJ279069
IL10 CGACTTTAAATCTCCCATCGAC
GCATTGGACGATCTCTTTCTT
AB118099
IL12b ATGTGGTTACGGGAGGC
ATGTGGTTACGGGAGGC
AJ548830.1
TNF2 TGCTGCTCCATGTGTGGTGC
AGGGACGGGGAGCCTTGAT
DQ218473.1
MHC1 uda-hc GCAACCCAATTTCATGCAGG
ACACTCAATGCAGGTCTGGG
EU036638.1
IgM ACCTTAACCAGCCGAAAGGG
TGTCCCATTGCTCCAGTCC
X65263.1
IgT AGCACCAGGGTGAAACCA
GCGGTGGGTTCAGAGTCA
AY870265
EF1(house-keeping gene) GATCCAGAAGGAGGTCACCA
TTCCAT
AF498320
TGTGCT
TTCTCCTTACGTTCGACC
VP4 AGGAGATGACA
CCAGCGAATATT
days, the BF-2 cell monolayers were enzymatically disag-
gregated, ﬁxed with 3.7% formaldehyde in PBS for 15 min,
washed twice in PBS and permeabilised with 0.01% Triton
X-100 in PBS for 1 min. The cells were then incubated for
30 min  at room temperature with a 1:10 dilution of an anti-
IPNV-VP3 monoclonal antibody mAb  2F12 (Dominguez
et al., 1990) (courtesy of Dr. Julio Coll, INIA, Madrid), after
which they were washed in PBS that was supplemented
with 2% FBS and incubated for 30 min  at room tempera-
ture with a FITC-conjugated goat anti-mouse IgG antibody
(Sigma, Spain). The ﬂuorescence of the cell suspensions
was measured on a Coulter XL ﬂow cytometer (Beckmann-
Coulter, Spain), determining the background ﬂuorescence
from uninfected cells and infected cells that were stained
with an irrelevant antibody.
2.10. Virus isolation in ﬁsh survivors
The remaining virus was isolated from survivors using
standard methods, and dilutions of the obtained samples
(1:100) were then inoculated into BF-2 cell monolayers
grown in 24-well plates (Falcon, Becton-Dickinson, France).
The monolayers were incubated at 19 ± 1 ◦C and observed
daily for CPEs. The samples were considered negative when
no CPEs were observed after two passages.
2.11. Expression of immune-related genes in vaccinated
or infected ﬁsh and in IPNV infection survivors
In an earlier study, we analysed gene expression in rain-
bow trout at seven days pv with the pcDNA.VP2 vaccine
using a speciﬁc microarray (Ballesteros et al., 2012a). Some
of the genes that were previously shown to be differen-
tially expressed (>2-fold) following oral VP2-vaccination
were evaluated in trout to determine the immunomodu-
latory ability of the virus or the vaccine during the early
and late stages of infection. In this study, the ﬁsh wereCC
ACACCG
ACCA
M18049.1
ﬁrst processed when the virus begins to cause early deaths
(10 days pi) and again at 45 days post-challenge when ﬁsh
did not exhibit clinical symptoms. No virus was  recovered
from the vaccinated trout in cell cultures. The primers and
probes that were used to analyse these genes via RT-qPCR
are described in Table 1. The assessed genes were IFN;
cytokine/interleukin-related genes, such as IL8 (Sanchez
et al., 2007), IL10 (Inoue et al., 2005), IL11 (Wang et al.,
2005), the p40 b chain of the IL12 heterodimer (Fischer
et al., 2006) and tumour necrosis factor (TNF2), similar
to TNF (Zou et al., 2002); and genes related to adaptive
immune responses, such as MHC1 (Hansen and LaPatra,
2002), IgM (Lorenzen et al., 1993) and IgT (Zhang et al.,
2010).
2.12. Statistical analysis
Prior to the statistical analyses, the normality of the
distribution of the data was  checked and conﬁrmed using
the Shapiro–Wilk test. The data are presented as the
mean ± standard deviation of the results from three trout.
An analysis of variance (factorial ANOVAs) was run to
determine whether the differentially expressed genes
differed between the replicates for an individual gene,
followed by Tukey’s multiple comparison test for differ-
ences between the vaccinated group and the IPNV-infected
group. Student’s t-test was  used to compare some of the
paired samples. All the statistical analyses were run in SPSS
version 15. P values of less than 0.05 were considered sig-
niﬁcant.
3. Results3.1. Fish mortality
Seven days post-challenge, the ﬁsh from the mock-
vaccinated virus control group (IPNV) began to die as well
N.A. Ballesteros et al. / Veterinary Immunology and
Fig. 1. Percentage of accumulated mortality of rainbow trout vacci-
nated and challenged with IPNV after 15 days (pcDNA-VP2 + IPNV).
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.2. Persistence of IPNV in the ﬁsh survivors
The expression of the VP4 gene was determined via RT-
PCR and used as a measure of IPNV replication or the
iral load (Fig. 2). The relative expression of the VP4 gene
as found to be increased signiﬁcantly in the IPNV con-
rol group, whereas VP4 was only weakly expressed in
he pcDNA-VP2-vaccinated ﬁsh. The surviving ﬁsh from
he virus control group showed stronger expression in the
ills and liver, indicating that these organs are targets of
ig. 2. Effect of the IPNV vaccine on the IPNV carrier state in vacci-
ated and unvaccinated ﬁsh. The IPNV load was  determined through the
xpression of the non-structural VP4 gene analysed by real-time RT-PCR,
valuating its transcription in the kidneys of surviving ﬁsh at 45 days pi.
he  data is derived from three independent experiments ± standard devi-
tion (SD) for three individuals from each group: *statistically signiﬁcant
ifferences at P < 0.05. Immunopathology 165 (2015) 127–137 131
viral infection, at least during the chronic stage of infec-
tion. Weaker but detectable expression was recorded in the
pyloric caeca and kidney, and the lowest expression was
detected in the spleen. However, in the vaccinated ﬁsh, the
protection induced by the pcDNA-VP2 vaccine was demon-
strated by the very low or non-detectable expression of the
target gene in the examined organs.
These results indicate that there were signiﬁcantly
lower levels of the virus in the vaccinated ﬁsh (P < 0.05).
3.3. Expression of IPNV viral antigens in organs from
surviving ﬁsh, quantiﬁed by ﬂow cytometry
The recorded percentage of ﬂuorescent cells represents
the cells in which IPNV antigens (VP3) were expressed, as
detected in the indirect immunoﬂuorescence assay (Fig. 3).
The BF-2 cells inoculated with samples of different organ
homogenates from vaccinated and challenged ﬁsh showed
either negative results or very low levels (ranging from 1.1
to 4%) of ﬂuorescent cells (Fig. 3A). These results are con-
sistent with the weak expression of the VP4 gene observed
in the surviving ﬁsh and the non-recovery of the virus from
the inoculated BF cell monolayers. In contrast, the BF-2
cells inoculated with gill and kidney homogenates from the
virus control ﬁsh exhibited the greatest number of positive
ﬂuorescent cells, ranging from 65 to 86% (Fig. 3B) and show-
ing mean values of approximately 73 and 62% ﬂuorescent
cells, respectively (Fig. 3C). The spleen, liver and kidney
homogenate samples inoculated onto the BF-2 monolay-
ers also resulted in a high percentage of ﬂuorescent cells
(from 43 to 49%). These results indicate that despite the
absence of clinical symptoms in the IPNV control group of
ﬁsh, the virus remained virulent, maintaining its capacity
to infect and multiply in sensitive cells.
The histograms shown in Fig. 3C represent the average
levels and standard deviations of the percentages of ﬂuo-
rescent cells that were detected in the examined samples
and demonstrate the existence of signiﬁcant differences
between the unvaccinated and vaccinated ﬁsh.
3.4. Recovery of the virus from ﬁsh (vaccinated and
control) at 45 days post-infection
Among the seven ﬁsh that survived in the virus control
group, ﬁve produced a positive CPE in the cultured cells
after 24–48 h pi at the ﬁrst passage, along with most of the
samples from ﬁsh from the pcDNA + IPNV group (Table 2).
In contrast, none of the homogenates from the pcDNA-
VP2 + IPNV (vaccinated ﬁsh) group produced a positive CPE
at the ﬁrst passage in BF-2 cells.
The samples that failed to produce a positive CPE were
recovered from the cell cultures and re-inoculated into
new cell monolayers to perform a second blind passage to
amplify any potential small amounts of remaining virus.
All the samples from the virus controls that failed to pro-
duce a positive CPE in the initial assay generated a CPE in
the second passage, while the samples from the vaccinated
group still failed to produce a CPE. The identity of IPNV
was conﬁrmed via seroneutralisation or RT-PCR assays and
sequencing of the ampliﬁed product (data not shown).
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pressing
 group;
s at P < 0Fig. 3. Flow cytometry histograms (or percentages) of viral antigen ex
infection for 45 days. (A) pcDNA-VP2-challenged group; (B) virus control
for  three individuals from each group. *Statistically signiﬁcant difference
3.5. Expression of immune-related genes in vaccinated or
infected ﬁsh during the early and late stages of infection
The quantiﬁcation data from the RT qPCR assays are
shown in Fig. 4. The comparative results between the
groups are expressed in fold values and summarised in
Fig. 4 B1 (for the pcDNA-VP2-vaccinated ﬁsh relative to the
virus control ﬁsh at 45 days pi) and Fig. 4 B2 (for the virus
control ﬁsh at 45 days pi (i.e., “carriers”) relative to the virus
control ﬁsh at 10 days pi).
Greater up-regulation in the virus control ﬁsh was
recorded for the IL8 gene at 10 days post-challenge, when
the relative expression value for this gene had increased
early to 32.44 ± 12.84, while in the vaccinated ﬁsh the rel-
ative expression value was 9.34 ± 4.92. Up-regulation of BF-2 cells infected with homogenised tissue from ﬁsh surviving IPNV
 background ﬂuorescence is indicated. (C) Mean relative expression ± SD
.05.
IFN-1 was observed at 45 days post-challenge in the vac-
cinated ﬁsh (1.67 ± 069), which was the only instance in
which a gene showed higher expression compared with
its level in the IPNV control ﬁsh (0.97 ± 0.2). These results
agree with those previously obtained at 7 days (Ballesteros
et al., 2012b,c). Comparative analysis of gene expression
in the vaccinated ﬁsh and the virus control group at 45
days post-challenge revealed that only two genes, IFN-1
and IL12b, were up-regulated in the former group (Fig. 4B).
In the ﬁsh from the virus control group that were
examined at 10 and 45 days post-challenge (Fig. 4A and
B2), the transcription levels of the IFN-, IL-8, IL-12b, and
IgM genes were higher at the earlier time point, when
the virus was replicating, and the ﬁsh exhibited clinical
symptoms (affected ﬁsh darkened, swam in spirals, and
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Table  2
Isolation of IPNV in BF-2 cells from vaccinated and non-vaccinated rainbow trout that survived 45 days after challenge. Effects of the vaccine in viral
persistence.
Fish Virus Controla
(CPE)*
Vaccinated with empty
plasmid and infectedb
CPE
Vaccinated with
pcDNA.VP2 and infectedc
CPE
P1 P2 P1 P2 P1 P2
1 + + − + − −
2  − + − + − −
3  + + − + − −
4  − + + + − −
5  + + + + − −
6  + + + + − −
7  + + + + − −
a The ﬁsh were infected by immersion with IPNV, survivors sacriﬁced at 45 days pi and visceral homogenates were processed as indicated in Section 2.
b Fish vaccinated orally with pcDNA empty plasmid and infected after 15 days.
days. Su
s on cell
d
c
w
m
r
t
F
c
R
1
t
(c Fish vaccinated orally with pcDNA.VP2 plasmid and infected after 15 
* CPE, cytopathic effects on the monolayers; P1, P2, successive passage
eveloped exophthalmia and abdominal distension). In
ontrast, the induction of TNF-2,  IL10, MHC-I and IgT
as higher at 45 days post-challenge, when the virus was
ost likely persistent. The increase in IL10 expression
ecorded in the IPNV survivors was the greatest among all
he examined genes at 45 days post-challenge. Except for
ig. 4. Expression of immune-related genes in rainbow trout at 10 days pi and i
hallenged ﬁsh (pcDNA-VP2 + IPNV), virus control group (IPNV), mock-vaccinate
T-qPCR data are presented as the normalised mean relative expression (±stand
0  and 45 days pi (A). (B1) and (B2) summarise the comparative changes in gene ex
he  fold-change in expression in the pcDNA-VP2-vaccinated ﬁsh that survived to
B2)  The fold change in gene expression in the IPNV control group at 45 days pi rervivors at 45 days post infection were processed as in a.
 monolayers.
IL-12 and IgM, the differences in the expression levels of
the examined genes at 10 and 45 days were signiﬁcant.The expression of genes related to mucosal immunity
is of interest because the vaccine is administered orally.
Therefore, the effect of the virus and the vaccine on IgM and
IgT transcripts was evaluated in the surviving ﬁsh (Fig. 4).
n survivors at 45 days pi. Samples were processed from vaccinated and
d ﬁsh (PBS) and ﬁsh vaccinated with the empty plasmid (pcDNA). The
ard deviation) in three anterior kidneys from ﬁsh that were processed at
pression observed in each group of ﬁsh. The histograms in (B1) represent
 45 days pi relative to that in the surviving IPNV control ﬁsh at this time.
lative to that at 10 days pi. *Statistically signiﬁcant differences at P < 0.05.
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Constitutive expression of these genes was detected in the
head kidneys of the trout. In the virus control ﬁsh, the
transcription level of IgM at 10 days post-challenge was
signiﬁcantly higher than most of the levels recorded for
the other genes (except for IL8) and was higher than the
expression level of the same gene at 45 days. In contrast,
IgT expression was greater at 45 days post-challenge. The
vaccinated ﬁsh showed similar patterns of expression to
the virus control ﬁsh for the IgM and IgT genes, although at
lower levels.
4. Discussion
This study showed that in the asymptomatic surviving
trout that were vaccinated and then IPNV-challenged, the
viral load and infectivity had been lost at 45 days post-
challenge. The vaccine displayed strong antiviral activity,
measured based on the reduction of virus VP4 transcript
levels. The results agree with previous studies in which the
vaccine was administered in food pellets (Ballesteros et al.,
2014). The absence of positive isolation results after two
successive passages in cell cultures is sufﬁcient to consider
a sample negative following standard diagnostic protocols.
Thus, the vaccine induces several different immunomod-
ulatory effects that result in inhibition of viral replication.
The results of ﬂow cytometry analysis also supported the
existence of such inhibition, as the cells inoculated with
homogenate samples from vaccinated ﬁsh did not show
signiﬁcant levels of viral antigens. In contrast, our obser-
vations indicated that the virus remained infective in the
surviving IPNV control group from which it was recovered
in cell cultures; there are two peaks in ﬂuorescence inten-
sity, one contains fewer cells but with a much stronger
ﬂuorescence intensity, probably those in which the virus
is accumulating after replication.
Our RT-qPCR results demonstrated that IFN-1 tran-
script levels were up-regulated at 45 days post-challenge
in the vaccinated ﬁsh compared with the non-vaccinated
ﬁsh, with as were those of the IL-12 gene, which consti-
tuted an exception to the observed pattern, as most of the
examined genes showed higher expression levels in the
non-vaccinated infected ﬁsh (virus control) at 45 days post-
challenge. The relative expression values for the selected
genes were low in survivors, and most of the genes exhib-
ited higher levels in the virus control trout than in the
vaccinated trout. It appeared that the observed immune
responses were similar to those found in mammals, where,
once a vaccine has established certain mechanisms of pro-
tection, the responsiveness to the virus diminishes.
It is well established that the type I IFN system partic-
ipates in the ﬁrst line of defence against viral infections,
and many reports have described its multiple functions in
innate and adaptive immune responses (Das et al., 2007;
Robertsen, 2006; Robertsen et al., 2003; Zou and Secombes,
2011). The roles of IFN type 1 in the virulence of IPNV or
in the establishment of virus persistence have been dis-
cussed previously (Basanta et al., 2009; Collet et al., 2007;
McBeath et al., 2007), although the mechanism underlying
persistent IPNV infection is, to a large extent, unknown.
The importance of IFN in establishing or maintaining viral
persistence has been explored for other viruses relevant tod Immunopathology 165 (2015) 127–137
ﬁsh aquaculture, such as betanodavirus nervous necrosis
virus (Wu  and Chi, 2006). In addition, the induction of a
strong IFN response with poly I:C in carrier ﬁsh was not
found to suppress the IPNV carrier state of Atlantic salmon
broodstock (Lockhart et al., 2004).
The results of the present study agree with these earlier
data to some degree, as IPNV could be detected in sev-
eral organs of ﬁsh virus control that survived to 45 days
pi. Neither the expression of IFN nor that of other related
genes eliminated the virus, which could be re-isolated from
the asymptomatic ﬁsh in this group. The question is dif-
ferent for the pcDNA-VP2-challenged ﬁsh, which showed
slightly higher expression of IFN than the IPNV control ﬁsh
at 45 days post-challenge. The virus not only disappeared
from the surviving ﬁsh, in which very low expression of
the VP4 gene was  recorded, but its infectivity was  also lost.
pcDNA-VP2 is a DNA vaccine, and expression of the VP2
gene is expected to occur continuously for at least 60–90
days (de las Heras et al., 2010); thus, stimulation of IFN and
other immune-related genes could be induced for longer
periods than that for which the virus is present, possibly
contributing to viral elimination or removal. In addition,
persistence is not a well-understood process in viral infec-
tion, and many genes may be involved in the maintenance
of a sub-clinical infection.
In contrast to IFN-1 (which is considered a marker of
the innate immune response), the level of IFN- (which
is involved in adaptive and speciﬁc immunity) was  quite
low in the IPNV carrier trout and was  almost undetectable
in the vaccinated and IPNV survivor ﬁsh at 45 days post-
challenge. Marjara et al. (2011) reported similar results for
the expression of IFNs in Atlantic salmon survivors of IPNV
infection. While no signiﬁcant differences were found in
the expression level of IFN- relative to basal levels, a sig-
niﬁcant increase in the expression of IFN-1 was recorded.
There is little information regarding pro- and anti-
inﬂammatory cytokines in ﬁsh and their relationship with
viral infection and/or vaccination. In microarray assays
we previously performed in vaccinated ﬁsh, several inter-
leukin (IL) genes were found to be over-expressed, some of
which were selected for comparison in the vaccinated and
control ﬁsh (Ballesteros et al., 2012a,c,d) Here, we demon-
strate that the expression level of the anti-inﬂammatory
cytokine IL10 was  different in the IPNV-infected and VP2-
vaccinated trout. The fold change in expression observed
at 45 days post-challenge in the vaccinated ﬁsh relative to
the virus carrier ﬁsh indicated signiﬁcant down-regulation.
The expression of IFN-1 and a number of ILs was recently
studied during acute and persistent infection in Atlantic
salmon (Reyes-Cerpa et al., 2012). IL10 is a potent anti-
inﬂammatory cytokine in mammals, and IL8 is a chemokine
that induces endothelial activation for the recruitment of
immunocompetent cells. The increased expression of IL10
was  accompanied by failure to induce IL1b and IL8, indi-
cating that IPNV triggers an anti-inﬂammatory response,
which may  be one of the mechanisms that establishes per-
sistence.The results obtained in the present study, although in
younger rainbow trout, are consistent with those described
for salmon. Indeed, we recorded the largest increase of IL10
in IPNV carrier ﬁsh, which exhibited low levels of IL8. An
logy and
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mportant role of IL10 in establishing the persistence of sev-
ral animal viruses has been described previously (Brooks
t al., 2006; Wilson et al., 2011). Accordingly, the signiﬁ-
ant down-regulation of IL10 expression in the surviving
roup of pcDNA-VP2-challenged ﬁsh compared with the
irus carrier group is noteworthy. It can be speculated that
he activity of the VP2 vaccine contributes to the decrease
n the viral load of the kidney cells and, thus, to the down-
egulation of the anti-inﬂammatory response.
Another cytokine that was tested here was TNF2, which
s an important pro-inﬂammatory cytokine that is similar
o TNF (Wang et al., 2011) and is induced after viral infec-
ion (Poisa-Beiro et al., 2008). The trout that were carriers
f IPNV (either vaccinated or infected) did not express high
NF2 levels. This lag in TNF2 expression may  indicate no
ctivation of a potential TNF-induced apoptosis pathway;
his was also observed in experimentally infected Atlantic
almon (Ellis et al., 2010; McBeath et al., 2007).
MHC-1 was analysed because previous data have
emonstrated that this is regulated in most trout at 7 days
ost-vaccination (Ballesteros et al., 2012a). Here, we  found
ery low relative expression of MHC-1 in the vaccinated
nd infected ﬁsh, while the relative levels were 14-fold
igher in the virus group. MHC-I molecules are involved
n cell-mediated immunity through participating in anti-
en processing and presentation after viral infection, and
hey are important for host anti-viral immunity due to reg-
lating natural killer cell activity (Landis et al., 2008). Based
n our results, it appears that at the time of sampling, the
xpression of MHC-I, IL8 and IL12 was not enhanced by
he presence of the vaccine, and their roles in persistence
ay therefore be exerted earlier or may  be related to viral
bundance.
We also analysed the transcription of genes related
o mucosal immunity, such as IgM and IgT genes. Our
esults indicate that IgT is expressed in both vaccinated
nd virus control ﬁsh, but more intensely in the virus con-
rol carrier ﬁsh, which also exhibited higher expression
ompared with ﬁsh at 10 days post-challenge. The differ-
nces were statistically signiﬁcant. The expression of IgM at
0 days post-challenge was increased in both the pcDNA-
P2-challenged and IPNV control ﬁsh. It noteworthy that
esults from several other studies revealed that both IgM
nd IgT are up-regulated in response to the haemorrhagic
epticaemia virus, a rhabdovirus infecting salmonid ﬁsh,
ndicating that at early time points post-infection, both
gM+ and IgT+ cells are involved in the antiviral response
Aquilino et al., 2014). Here, it can be concluded that vac-
ination does not enhance the expression of IgM and IgT
bove the levels observed in the virus control carrier group,
ut rather, that it mimics viral activity and contributes to
aintaining these immunoglobulins at appreciable levels
n both groups of ﬁsh. However, it remains unclear what
mmune activity is being induced by the virus that persists
n surviving ﬁsh or by the VP2 gene, which was expressed
n several organs of the orally vaccinated ﬁsh. Some recent
tudies have focused on models of IPNV persistence in ﬁsh
hat may  be useful in studying the molecular and immuno-
ogical aspects of persistence and latency. Genes that are
nvolved in direct interactions or in the degradation of viral
roteins are up-regulated (Marjara et al., 2011), and the Immunopathology 165 (2015) 127–137 135
translation of a transcriptional repressor was shown to be
inhibited, suggesting involvement in the control of IPNV
replication and a role in maintaining a low number of viral
particles in persistently infected cells. In our current study,
the administered vaccine diminished the relative expres-
sion of the viral VP4 gene, which serves as a marker of
infection and of the infective virus. Thus, it is tempting to
speculate that as the viral load is low in the carrier ﬁsh,
the immune activity induced by the DNA vaccine may ulti-
mately contribute to the removal of the remaining virions.
Further work will be necessary to deﬁne the pathways
related to the activity of IFN and other cytokines or to the
activity of other relevant genes in long-term carriers of
IPNV as well as to investigate the possible enhancement of
antiviral responses mediated by vaccines. The availability
of new tools, such as microarrays and large-scale sequence
analysis, will surely generate abundant information, and
such efforts are likely to provide a better understanding of
the viral state of carrier ﬁsh.
In conclusion, we have demonstrated that both RT-qPCR
and ﬂow cytometry assays show remarkable differences
in viral detection between vaccinated and non-vaccinated
surviving ﬁsh. Indeed, no virus could be isolated from the
cell cultures inoculated with samples from the pcDNA-
VP2-challenged ﬁsh. However, the transcription of relevant
genes that are related to immunity was  detected in all
the ﬁsh, and, even at different levels, similar expression
proﬁles were observed in the virus control ﬁsh and the
vaccinated ﬁsh. As a DNA vaccine, the expression of the
VP2 transgene could explain this similarity and its contri-
bution to maintaining immune responses. Thus, under our
experimental conditions, the orally administered pcDNA-
VP2 vaccine not only induces great protection against
IPNV but also prevents persistent stages in the examined
survivors.
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